Dr. Kalkanis succeeds William Conway, MD, who is stepping down after more than four decades with the health system.
He joined Henry Ford in 2004 and is chair of the system’s department of neurosurgery.
As CEO, Dr. Kalkanis will be responsible for clinical performance across 40 specialties and provide strategic leadership and direction to researchers and physicians at the 1,900-member group.
He will also serve as Henry Ford’s senior vice president and chief academic officer, where he will look to advance the system’s research and education programs as well as its population health and accountable care initiatives.
More articles on spine:
Dr. Jeffrey Carlson implants M6-C artificial cervical disc — 4 insights
SeaSpine reports 25,000th implantation of PEEK device for spinal disorders
AANS partnership, biologics R&D & legislative influence: 9 big AAOS updates in 2019
